Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids
Sergio M. Pontejo(National Institutes of Health), Philip M. Murphy(National Institute of Allergy and Infectious Diseases), David N. Garboczi(National Institutes of Health), Acacia F. Dishman(Medical College of Wisconsin), Jaime de Anda(California NanoSystems Institute), Gerard C. L. Wong(California NanoSystems Institute), Kevin Barnes(National Institutes of Health), Ángela Ballesteros(National Institute on Deafness and Other Communication Disorders), Brian F. Volkman(Medical College of Wisconsin), Allison Zhao(National Institutes of Health), Ernest Y. Lee(California NanoSystems Institute), Sophia Martinez(National Institutes of Health), Haleh Alimohamadi(California NanoSystems Institute)
Cited by 6
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
Viral exploitation and subversion of the immune system through chemokine mimicry
|Nature Immunology|2001|335
Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions
|Proceedings of the National Academy of Sciences|2011|330
Chemokines and Chemokine Receptors: Biology and Clinical Relevance in Inflammation and AIDS
|Annual Review of Medicine|1999|284